Trials
Regulations
Contact Us

Welcome to pediculosis.com

Pediculosis.com is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.

btn-readmore

Industry News

      

Scientific News

newsimg-ind

newsimg-sci

22.02.17 | Assessment of oral ivermectin versus shampoo in the treatment of pediculosis

A study conducted in two neighbouring villages of Sine-Saloum, Senagal, analysed the effect of using oral Ivermectin and shampoo in the treatment of pediculosis and revealed that whilst oral ivermectin is more highly effective in treating pediculosis compared with shampoo, ivermectin resitance may emerge during treatment.

15.05.17 | A randomized clinical study comparing a head lice shampoo, (Licener®) with an anti-head lice product containing dimethicone (Jacutin® Pedicul Fluid)

A new study conducted between July and November 2016 in households of two villages in Egypt compared the safety and efficacy of a shampoo-based head lice treatment (Licener®) with an anti-head lice product (Jacutin® Pedicul Fluid) via a randomized and controlled clinical study.

07.04.17 | A randomised clinical trial to evaluate the efficacy and safety of a new pediculicide made with saponified olive oil in the eradication of head lice.

A new study has compared the efficacy and safety of a new pediculicide, Inex Pediculicide Soap® with Paranix® via a randomised clinical trial involving children diagnosed with pediculosis and 6 paediatricians from the community of Madrid, Spain.

16.03.17 | Randomised trials to assess the efficacy of Australian essential oils in the treatment of head lice

A new study has compared the efficacy of a head lice treatment containing Australian eucalyptus oil and Leptospermum petersonii (EO/LP Solution) with a neurotoxic treatment containing pyrethrins and piperonyl butoxide (P/PB Mousse) via a randomised controlled study.

16.09.16 | Efficacy of Abametapir Against Eggs of Human Head and Body Lice

A study undertaken to determine the ovicidal efficacy of abametapir against eggs of both human head and body lice has revealed that abametaphir has an 100% ovicidal activity in vitro assessments and therefore able to inhibit hatching of both head and body louse eggs if used in specific concetrations.

09.06.17 | Ivermectin lipid-based nanocarriers as novel formulations against head lice

A new study investigating the insecticidal activity of ivermectin-loaded lipid nanocapsules (IVM-LNC) against permethrin-resistant head lice has highlighted the effectiveness in the encapsulation of ivermectin (IVM) into stable LNC dispersion with a potential clinical activity against head lice .

08.06.17 | Identification of Novel Voltage-Gated Sodium Channel Mutations in Human Head and Body Lice

A new study investigating louse populations from Iran has revealed that 100% of all specimens collected from the Provinces of West-Azerbaijan and Zanjan have at least one of six novel mutations potentially associated with kdr resistance in body and head lice.

07.05.17 | Novel polymeric micelles for insect pest control: encapsulation of essential oil monoterpenes inside a triblock copolymer shell for head lice control

A new study has investigated the pediculicidal activity of micellar systems containing a 5 wt% of poloxamer 407 and 1.25 wt% of the different monoterpenes using an ex vivo immersion test and revealed that aqueous formulations are effective against head lice with mortality ranging from 30 to 60%.

16.02.17 | Arrestant Effect of Human Scalp Components on Head Louse Behaviour

A new study analysing the effect of human scalp components on the behavior of adult head lice has shown for the first time the effect of host components conditioning on head lice behavior.

16.02.17 | Head Lice of Pygmies Reveal the Presence of Relapsing Fever Borreliae

A molecular screening of pygmies’ head lice in the Republic of Congo has identified the presence of a dangerous human pathogen, Borrelia reccurentis, the causative agent of relapsing fever, in ten clade A head lice, which was not reported in the republic of Congo and B. theileri in one head louse.

morenews-ind.png morenews-sci.png
  • Company News
  • Pediculosis.com: The world's only specialist website for the head lice industry
  • Scientific News
  • Regulatory News
  • Licecomb Engineering

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved